Robert G. Petit
Direttore Tecnico/Scientifico/R&S presso OS Therapies, Inc.
Profilo
Robert G.
Petit's current job(s) include Senior VP & Head-Early Clinical Development at Orionis Biosciences, Inc., Chief Medical & Scientific Officer at OS Therapies, Inc., and Principal at RGP Biotech, LLC.
Dr. Petit's former job(s) include Director-Medical Strategy at Bristol Myers Squibb Co. from 2005 to 2010, Vice President-Clinical Development at MGI PHARMA, Inc. and Aesgen, Inc., and Chief Scientific Officer & Executive VP at Advaxis, Inc. from 2010 to 2019.
He also briefly served as Chief Scientific Officer at CTx Operations, Inc. in 2019.
Dr. Petit obtained his undergraduate degree from Indiana State University and his doctorate degree from The Ohio State University.
Posizioni attive di Robert G. Petit
| Società | Posizione | Inizio |
|---|---|---|
OS Therapies, Inc.
 OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Direttore Tecnico/Scientifico/R&S | 01/09/2019 |
| RGP Biotech, LLC | Corporate Officer/Principal | 01/06/2019 |
Orionis Biosciences, Inc.
 Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/03/2022 |
Precedenti posizioni note di Robert G. Petit
| Società | Posizione | Fine |
|---|---|---|
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Direttore Tecnico/Scientifico/R&S | 01/12/2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2010 |
Aesgen, Inc.
 Aesgen, Inc. Pharmaceuticals: MajorHealth Technology Aesgen, Inc. develops pharmaceutical products resulting from cancer research collaborations, and specialized delivery of peptides, proteins, and small molecules for critical care. The company is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Corporate Officer/Principal | - |
| AYALA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 03/06/2019 |
Formazione di Robert G. Petit
| Indiana State University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 7 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Aesgen, Inc.
Aesgen, Inc. Pharmaceuticals: MajorHealth Technology Aesgen, Inc. develops pharmaceutical products resulting from cancer research collaborations, and specialized delivery of peptides, proteins, and small molecules for critical care. The company is headquartered in Princeton, NJ. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Technology Services |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Commercial Services |
| RGP Biotech, LLC |
- Borsa valori
- Insiders
- Robert G. Petit
